Bio Chestnut Bud NDC 43857-0438

NDC codes

FDA NDC Directory

Product NDC (as listed)43857-0438Labeler and product segments. Claims need a package NDC.

Product NDC at billing width43857-0438Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
43857-0438-1	43857043801	30 mL in 1 PACKAGE (43857-0438-1)Marketed from Mar 2, 2017

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Bio Chestnut Bud
Generic name (nonproprietary): aesculus hippocastanum flower, aesculus hippocastanum leaf
Active ingredients: Aesculus hippocastanum flower — 6 [hp_X]/mLAesculus hippocastanum leaf — 6 [hp_X]/mL
Dosage form: Liquid
Route: Oral
Labeler: BioActive Nutritional, Inc
Product type: Over-the-counter drug
Marketing category: Unapproved homeopathic
Marketing start: Mar 2, 2017
Listing expires: Dec 31, 2026
Identifiers: Product ID 43857-0438_dcd3c6c6-a9f5-4e4c-ac16-eafda431694fSPL ID dcd3c6c6-a9f5-4e4c-ac16-eafda431694fSPL set ID e9817932-c781-4148-b7bc-adf7942308afUNII KK0Z92II8M, Z49U891FNQ

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N443857043801 followed by a unit qualifier and the quantity

Package 43857-0438-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 30, 2024.

Indications (excerpt from the label)

INDICATIONS: For those who fail to learn from experience, repeating of the same patterns of mistakes again and again.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)